Prof. Dr. Ursula Quitterer
Prof. Dr. Ursula Quitterer
Full Professor at the Department of Chemistry and Applied Biosciences
Deputy head of Institute of Pharmaceutical Sciences
- Work phone +41 44 632 98 01
- Fax print +41 44 632 11 03
- Work phone +41 79 594 10 40 Alternate(Alt.)
- phone +41 44 632 98 06 Secretariat(Sec.)
- Tel: +41 44 632 98 01
- contactsV-Card (vcf, 1kb)
Additional information
Ursula Quitterer is a Full Professor of Molecular Pharmacology in the Institute of Pharmaceutical Sciences at ETH Zurich since February 2006.
In 1966 Ursula Quitterer was born in Passau, Germany. She studied pharmaceutical sciences in Regensburg and obtained a Ph.D. degree in 1994 from the University of Mainz. After a postdoctorate at Roche Biosciences Inc. in Palo Alto (USA), she joined the Institute of Pharmacology at the University of Würzburg (Deutschland) as a senior scientist. In 1999 she was awarded the "Bayerische Habilitationsförderpreis". Research visits at Medigene Inc. (Munich) and at the Heinrich-Pette-Institute of Experimental Virology and Immunology (Hamburg) followed. She achieved the habilitation for pharmacology and toxicology in 2001. From 2004 to 2005 she directed the teaching program of pharmacology and toxicology for pharmaceutical and life science students at the University of Wuerzburg.
Research interests include the pathomechanisms of cardiovascular disease and atherosclerosis with particular focus on the relationship between cardiovascular risk factors, the dysfunction of signal transduction mechanisms and end organ damage. The research aims to identify pharmacological targets and to delineate therapeutic concepts to prevent and retard the progression of cardiovascular disease.
Course Catalogue
Autumn Semester 2024
Number | Unit |
---|---|
535-0001-00L | Introduction to Pharmaceutical Sciences I |
535-0011-00L | Drug Seminar |
535-0041-00L | Pharmacology and Toxicology III |
535-0521-AAL | Pharmacology and Toxicology I+II |
535-0521-00L | Pharmacology and Toxicology I |
535-0900-00L | Seminars on Drug Discovery and Development |